Luwei Xu

784 total citations
38 papers, 587 citations indexed

About

Luwei Xu is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luwei Xu has authored 38 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luwei Xu's work include Tissue Engineering and Regenerative Medicine (8 papers), Microbial Metabolic Engineering and Bioproduction (6 papers) and Urological Disorders and Treatments (5 papers). Luwei Xu is often cited by papers focused on Tissue Engineering and Regenerative Medicine (8 papers), Microbial Metabolic Engineering and Bioproduction (6 papers) and Urological Disorders and Treatments (5 papers). Luwei Xu collaborates with scholars based in China and United States. Luwei Xu's co-authors include Yu‐Zheng Ge, Liuhua Zhou, Zheng Xu, Rui-Peng Jia, Ruiyang Wu, Feng Zhao, Yang Li, Changcheng Zhou, Jiageng Zhu and Jingyu Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioresource Technology and Scientific Reports.

In The Last Decade

Luwei Xu

35 papers receiving 581 citations

Peers

Luwei Xu
Vincent Kuek Australia
Leila Jazayeri United States
Lin Yuan China
Hyun-keun Kim South Korea
Luwei Xu
Citations per year, relative to Luwei Xu Luwei Xu (= 1×) peers Lianju Shen

Countries citing papers authored by Luwei Xu

Since Specialization
Citations

This map shows the geographic impact of Luwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luwei Xu more than expected).

Fields of papers citing papers by Luwei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luwei Xu. The network helps show where Luwei Xu may publish in the future.

Co-authorship network of co-authors of Luwei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Luwei Xu. A scholar is included among the top collaborators of Luwei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luwei Xu. Luwei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Xu, Luwei, et al.. (2025). Advances in multi-omics technologies for identifying metabolic engineering targets and improving lipid production in microalgae. Bioresource Technology. 429. 132501–132501. 1 indexed citations
4.
Zhang, Zixu, Ying‐Shuang Xu, Zijia Li, et al.. (2024). Turning waste into treasure: A new direction for low-cost production of lipid chemicals from Thraustochytrids. Biotechnology Advances. 73. 108354–108354. 4 indexed citations
5.
Wu, Di, Jingyu Liu, Luwei Xu, et al.. (2024). Neutrophil-derived nanovesicles deliver IL-37 to mitigate renal ischemia-reperfusion injury via endothelial cell targeting. Journal of Controlled Release. 370. 66–81. 11 indexed citations
6.
Xu, Luwei, et al.. (2024). Selecting Endogenous Promoters for Improving Biosynthesis of Squalene in Schizochytrium sp.. Biotechnology Journal. 19(10). e202400237–e202400237. 11 indexed citations
7.
Zhang, Zixu, Luwei Xu, Ying‐Shuang Xu, et al.. (2023). Integration of genetic engineering and multi-factor fermentation optimization for co-production of carotenoid and DHA in Schizochytrium sp. Bioresource Technology. 394. 130250–130250. 19 indexed citations
8.
Yang, Bin, et al.. (2023). Autologous Endothelial Progenitor Cells and Bioactive Factors Improve Bladder Regeneration. Tissue Engineering Part C Methods. 30(1). 15–26. 1 indexed citations
9.
Yang, Li, Ning Liu, Xi Hong, et al.. (2022). Pan-Cancer Transcriptomic Analysis Identifies PLK1 Crucial for the Tumorigenesis of Clear Cell Renal Cell Carcinoma. SHILAP Revista de lepidopterología. 4 indexed citations
10.
Li, Yang, Luwei Xu, Ning Liu, et al.. (2022). Tumor Cell-Derived Exosomal circ-PRKCI Promotes Proliferation of Renal Cell Carcinoma via Regulating miR-545-3p/CCND1 Axis. Cancers. 15(1). 123–123. 16 indexed citations
11.
Xu, Zheng, et al.. (2021). NLRP3 inflammasome promoted the malignant progression of prostate cancer via the activation of caspase-1. Cell Death Discovery. 7(1). 399–399. 35 indexed citations
12.
Zhou, Changcheng, Liuhua Zhou, Jingyu Liu, et al.. (2020). Kidney extracellular matrix hydrogel enhances therapeutic potential of adipose-derived mesenchymal stem cells for renal ischemia reperfusion injury. Acta Biomaterialia. 115. 250–263. 49 indexed citations
13.
Zhao, Feng, Liuhua Zhou, Luwei Xu, et al.. (2019). Hypoxia-Preconditioned Adipose-Derived Endothelial Progenitor Cells Promote Bladder Augmentation. Tissue Engineering Part A. 26(1-2). 78–92. 11 indexed citations
14.
Li, Yang, Yu‐Zheng Ge, Luwei Xu, & Rui-Peng Jia. (2019). Circular RNA ITCH: A novel tumor suppressor in multiple cancers. Life Sciences. 254. 117176–117176. 71 indexed citations
15.
Ge, Yu‐Zheng, Luwei Xu, Changcheng Zhou, et al.. (2017). A BAP1 Mutation-specific MicroRNA Signature Predicts Clinical Outcomes in Clear Cell Renal Cell Carcinoma Patients with Wild-type BAP1. Journal of Cancer. 8(13). 2643–2652. 20 indexed citations
16.
Ge, Yu‐Zheng, Zheng Xu, Luwei Xu, et al.. (2014). Pathway analysis of genome-wide association study on serum prostate-specific antigen levels. Gene. 551(1). 86–91. 13 indexed citations
17.
Ge, Yu‐Zheng, Luwei Xu, Rui-Peng Jia, et al.. (2014). Association of polymorphisms in estrogen receptors (ESR1 and ESR2) with male infertility: a meta-analysis and systematic review. Journal of Assisted Reproduction and Genetics. 31(5). 601–611. 26 indexed citations
18.
Ge, Yu‐Zheng, Ruiyang Wu, Hui Xin, et al.. (2014). Circulating endothelial progenitor cell: a promising biomarker in clinical oncology. Medical Oncology. 32(1). 332–332. 16 indexed citations
19.
Ge, Yu‐Zheng, Luwei Xu, Rui-Peng Jia, et al.. (2013). The association between RASSF1A promoter methylation and prostate cancer: evidence from 19 published studies. Tumor Biology. 35(4). 3881–3890. 22 indexed citations
20.
Jia, Ruipeng, Luwei Xu, Qi Su, et al.. (2008). Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer. Asian Journal of Andrology. 10(5). 758–764. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026